Molecular diagnostics on indication of maturity onset diabetes of the young; results from 184 patients;Moleculaire diagnostiek bij aanwijzingen voor 'maturity onset diabetes of the young'; resultaten bij 184 patiënten

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 3, 2005, Pages 139-143

  Loseikoot, M ^a,b   Broekman, A J ^a,c   Breuning, M H ^a,c   De Koning, E J P ^a,d   Romijn, J A ^a,e   Maassen, J A ^a,f  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Laboratorium Voor DNA diagnostiek   (Netherlands)

^c Klinisch Moleculair Geneticus ^*  (Netherlands)

^d Afd Nefrologie

^e Afd Endocrinol Stofwiss

^f Afd Moleculaire Celbiologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; NUCLEAR FACTOR I;

ARTICLE; CODON; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FAMILY HISTORY; GENE; GENE INSERTION; GENE MUTATION; GLUCOKINASE GENE; HNF 1A GENE; HNF 4A GENE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; MATURITY ONSET DIABETES OF THE YOUNG TYPE 1; MATURITY ONSET DIABETES OF THE YOUNG TYPE 2; MATURITY ONSET DIABETES OF THE YOUNG TYPE 3; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PROGNOSIS;

ADULT; AGE OF ONSET; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MALE; MUTATION; NUCLEAR PROTEINS; PEDIGREE; PHOSPHOPROTEINS; TRANSCRIPTION FACTORS;

EID: 12244259734     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hattersley AT. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 1998;15: 15-24.
2. Maassen JA, Lemkes HHPJ, Losekoot M. Van gen naar ziekte; 'maturity-onset diabetes of the young' (MODY), monogenetisch overervende vormen van diabetes mellitus. Ned Tijdschr Geneeskd 2001; 145:1352-3.
3. Ouweland JM van den, Lemkes HH, Ruitenbeek W, Sandkuijl LA, Vijlder MF de, Struyvenberg PA, et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992;1:368-71.
4. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992;340:1376-9.
5. Maassen JA, Ouweland JMW van den, Losekoot M, Lemkes HHPJ. Van gen naar ziekte; mutatie in mitochondrieel DNA en maternaal overervende diabetes mellitus met doofheid (MIDD). Ned Tijdschr Geneeskd 2001;145:1153-4.
6. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependant diabetes mellitus. Nature 1992;356:721-2.
7. 3). Nature 1996;384:455-8.
8. 1). Nature 1996;384:458-60.
9. 4) linked to IPF1. Nat Genet 1997;17:138-9.
10. 2) associated with MODY. Nat Genet 1997;17:384-5.
11. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999;23:323-8.
12. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, et al. Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 2001;50 Suppl 1:8101-7.
13. Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 2002;34: 207-16.
14. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003;362:1275-81.
15. Bingham C, Bulman MP, Ellard S, Allen LI, Lipkin GW, Hoff WG, et al. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 2001;68:219-24.
16. Velho G, Froguel P. Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol 1998;138: 233-9.
17. FraylingTM, Bulman M, Ellard S, Appleton M, Dronsfield MJ, Mackie ADR, et al. Mutations in the hepatocyte nuclear factor 1 alpha gene are a common cause of maturity-onset diabetes of the young in the United Kingdom. Diabetes 1997;46:720-5.
18. Ellard S. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Hum Mutat 2000;16: 377-85.
19. 4 families: functional and pathological consequences. J Mol Endocrinol 2001; 27:11-29.
20. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, et al. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001;50 Suppl 1: S94-100.
21. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003;21:577-81.
22. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaine M, Sun F, et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993;328:697-702.
23. Shepherd M. 'I'm amazed I've been able to come off injections': patients' perceptions of genetic testing in diabetes. Report of the Janet Kinson Lecture, Diabetes UK 2003, including commentary by K.MacLeod. Pract Diab Int 2003;20:338-43.